Paper41423596
Cost-effectiveness of primary care-based risk assessment and hereditary cancer genetic testing.
Devine B and 12 others. BMC Prim Care, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Cost-effectiveness of primary care-based risk assessment and hereditary cancer genetic testing. Papers, record 41423596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41423596
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cost-effectiveness of primary care-based risk assessment and hereditary cancer genetic testing.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Testing | Major topic |
| Primary Health Care | Major topic |
| Early Detection of Cancer | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Cost-Benefit Analysis | |
| Cost-Effectiveness Analysis | |
| Risk Assessment | |
| Female | |
| Male | |
| Middle Aged | |
| Quality-Adjusted Life Years |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U01 CA232795 | NCI NIH HHS | United States | U01CA232795 | PubMed and NIH | NIH RePORTER |
| U01CA232795 | National Cancer Institute, NIH | U01CA232795 | PubMed and NIH | NIH RePORTER | |
| UL1-TR002319 | NIH National Institute of Health & NCI National Cancer Institute | UL1TR002319 | PubMed | NIH RePORTER | |
| KL2-TR002317 | NIH National Institutes of Health & NCI National Cancer Institute | KL2TR002317 | PubMed | NIH RePORTER | |
| TL1-TR002318 | NIH National Institutes of Health & (NCATS) National Center for Advancing Translation Sciences | TL1TR002318 | PubMed | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04746794 | Early Detection of GEnetic Risk (EDGE) | Derived from the trial | Yes |
Source ClinicalTrials.gov
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25698379 | Practical opportunities to improve early detection and prevention of colorectal cancer (CRC) in members of high-risk families. | Dig Dis Sci | 2015 | https://conductscience.org/library/papers/25698379 | PubMed |
| 2 | 32601386 | Clinical outcomes of a genomic screening program for actionable genetic conditions. | Genet Med | 2020 | https://conductscience.org/library/papers/32601386 | PubMed |
| 3 | 36386046 | Barriers, interventions, and recommendations: Improving the genetic testing landscape. | Front Digit Health | 2022 | https://conductscience.org/library/papers/36386046 | PubMed |
| 4 | 37856201 | NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024. | J Natl Compr Canc Netw | 2023 | https://conductscience.org/library/papers/37856201 | PubMed |
| 5 | 33119106 | Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States. | JAMA Netw Open | 2020 | https://conductscience.org/library/papers/33119106 | PubMed |
| 6 | 22446623 | A self-administered family history questionnaire improves identification of women who warrant referral to genetic counseling for hereditary cancer risk. | Gynecol Oncol | 2012 | https://conductscience.org/library/papers/22446623 | PubMed |
| 7 | 38353949 | Cost-Effectiveness of Population-Based Multigene Testing for Breast and Ovarian Cancer Prevention. | JAMA Netw Open | 2024 | https://conductscience.org/library/papers/38353949 | PubMed |
| 8 | 37435610 | Payer reimbursement practices and incentives for improving interpretation of germline genetic testing. | J Law Biosci | 2023 | https://conductscience.org/library/papers/37435610 | PubMed |
| 9 | 31388181 | Genetic testing, insurance discrimination and medical research: what the United States can learn from peer countries. | Nat Med | 2019 | https://conductscience.org/library/papers/31388181 | PubMed |
| 10 | 40233717 | Precision oncology and genetic ancestry: The science behind population-based cancer disparities. | Cancer Cell | 2025 | https://conductscience.org/library/papers/40233717 | PubMed |
| 11 | 33373667 | Design of a study to implement population-based risk assessment for hereditary cancer genetic testing in primary care. | Contemp Clin Trials | 2021 | https://conductscience.org/library/papers/33373667 | PubMed |
| 12 | 21350618 | CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. | J Pharmacol Pharmacother | 2010 | https://conductscience.org/library/papers/21350618 | PubMed |
| 13 | 32642924 | Knowledge, Attitudes, Willingness to Pay, and Patient Preferences About Genetic Testing and Subsequent Risk Management for Cancer Prevention. | J Cancer Educ | 2022 | https://conductscience.org/library/papers/32642924 | PubMed |
| 14 | 29998407 | Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark. | Ann Surg Oncol | 2018 | https://conductscience.org/library/papers/29998407 | PubMed |
| 15 | 40053353 | Strategies to Assess Risk for Hereditary Cancer in Primary Care Clinics: A Cluster Randomized Clinical Trial. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/40053353 | PubMed |
| 16 | 35144679 | Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system. | Hered Cancer Clin Pract | 2022 | https://conductscience.org/library/papers/35144679 | PubMed |
| 17 | 34638366 | Data on Utility in Cost-Utility Analyses of Genetic Screen-and-Treat Strategies for Breast and Ovarian Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34638366 | PubMed |
| 18 | 24567435 | Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. | J Clin Oncol | 2014 | https://conductscience.org/library/papers/24567435 | PubMed |
| 19 | 28632866 | Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. | JAMA | 2017 | https://conductscience.org/library/papers/28632866 | PubMed |
| 20 | 38421676 | MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations. | JAMA Oncol | 2024 | https://conductscience.org/library/papers/38421676 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41423596
GET https://conductscience.org/api/papers/v1/41423596/references?page=2